Represents the amount of non-cash interest expense on liability related to sale of future royalties and milestones.

No definition available.

Name:	depo_NonCashInterestExpenseOnLiabilityRelatedToSaleOfFutureRoyalties
Namespace Prefix:	depo_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the amount of non-cash royalty revenue related to sale of future royalties.

+ References

No definition available.

+ Details

Name:	depo_NonCashRoyaltyRevenueFromSaleOfFutureRoyalties
Namespace Prefix:	depo_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_DebtInstrumentInterestRateEffectivePercentage
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_DeferredRevenueArrangementLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585

+ Details

Name:	us-gaap_ProceedsFromSaleOfIntangibleAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_DeferredRevenueArrangementTypeAxis=depo_FutureRoyaltyLiabilityArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

LIABILITY RELATED TO SALE OF FUTURE ROYALTIES (Details) (USD $)	3 Months Ended		0 Months Ended
	Mar. 31, 2014	Dec. 31, 2014	Oct. 18, 2013	Mar. 31, 2015
Future royalties liability
Non-cash PDL royalty revenue	$ 42,784,000
Outstanding balance of the liability recognized in Non-cash royalty revenue	42,784,000
Non-cash interest expense recognized	5,379,000
Liability related to sale of future royalties
Future royalties liability
Non-cash PDL royalty revenue	42,800,000	147,000,000
Effective interest rate (as a percent)				10.00%
Outstanding balance of the liability recognized in Non-cash royalty revenue	42,800,000	147,000,000
Non-cash interest expense recognized	5,400,000
Liability related to sale of future royalties \| PDL BioPharma
Future royalties liability
Royalty and milestone payments received			$ 240,500,000